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A B S T R A C T
Length heteroplasmy (LH) in mitochondrial (mt)DNA is usually observed in homopolymeric tracts and
manifest as mixture of various length variants. The generally used difference-coded annotation to report
mtDNA haplotypes does not express the degree of LH variation present in a sample, even more so, it is
sometimes difﬁcult to establish which length variants are present and clearly distinguishable from
background noise. It has therefore become routine practice for some researchers to call the dominant
type, the ‘‘major molecule’’, which represents the LH variant that is most abundant in a DNA extract. In
the majority of cases a clear single dominant variant can be identiﬁed. However, in some samples this
interpretation is difﬁcult, i.e. when (almost) equally quantitative LH variants are present or when
multiple sequencing primers result in the presentation of different dominant types. To better understand
those cases we designed amplicon sizing assays for the ﬁve most relevant LH regions in the mtDNA
control region (around ntps 16,189, 310, 460, 573, and the AC-repeat between 514 and 524) to determine
the ratio of the LH variants by ﬂuorescence based amplicon sizing assays. For difﬁcult LH constellations
derived by Sanger sequencing (with Big Dye terminators) these assays mostly gave clear and
unambiguous results. In the vast majority of cases we found agreement between the results of the
sequence and amplicon analyses and propose this alternative method in difﬁcult cases.
 2010 Elsevier Ireland Ltd.
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Length heteroplasmy (LH) describes the co-existence of at least
two populations of mitochondrial (mt)DNA molecules in a DNA
extract that differ in the number of nucleotides and therefore in
their length. This generally leads to difﬁculties when Sanger
sequencing data are to be interpreted, as the individual nucleotide
sequences overlay after LH regions and appear as blurred pattern.
While LH is usually observed in homopolymeric tracts when the
number of identical adjacent nucleotides is greater than eight (for
C-tracts), it has also been found in the AC-repeat and less often in
shorter length variants of the control region (CR) [1–5]. In rare
cases LH has even been observed in non-repetitive sequences [6].
The human mtDNA CR comprises ﬁve regions where LH occurs
regularly and it is most frequently observed in the polycytosine
tracts of the two hypervariable regions, HVS-I and HVS-II (Fig. 1)
[3,5,7–10]. More than half the samples of a systematic study on
5015 individuals exhibited length heteroplasmy somewhere in the
control region [11], whereas typical frequencies for LH to appear in* Corresponding author. Tel.: +43 512 9003 70640; fax: +43 512 9003 73640.
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Open access under CC BY-NC-ND license.polycytosine tracts are 12–20%, 45%, and 3–5% for HVS-I, II and III,
respectively [11–15]. Note that the frequency of LH in HVS-I can
also reach much higher levels exceeding 50% in populations where
the transition T16189C that leads to an uninterrupted polycytosine
tract represents a common and haplogroup (hg)-speciﬁc signature
mutation (e.g. hg B in East Asia and Native America [11]).
The biological relevance of LH is not yet fully understood.
Tissues of an individual may display LH to various extents [16],
especially when they go through a tight bottleneck in develop-
ment, such as observed in mitochondria of hair shafts. The
interpretation of LH in population genetics is usually disregarded.
Forensic science sometimes also does not take LH into account
when interpreting evidence (exclusion scenarios) and when the
rarity of a sequence is determined in a database search. Since
quantitative information (on themixture of LH variants) cannot be
captured by the difference-coded annotation of a haplotype (with
respect to the revised Cambridge Reference Sequence, rCRS [17])
the number of detectable LH variants is not described properly.
Also, it is sometimes technically difﬁcult to precisely distinguish
LH variants from background noise, especially since their depiction
by the raw data may vary depending on the sequencing chemistry
used. PCR primers, Taq and other polymerases, sequencing primers
and the version of the sequencing kit do have an effect on the
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Fig. 1. Schematic representation of the amplicon location for the analysis of the ﬁve
targeted length heteroplasmic regions within the mtDNA control region. X-axis
sized in bp. The hypervariable regions range from positions 16,024–16,365 (HVS-I),
73–340 (HVS-II) and 438–574 (HVS-III), respectively.
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sequence-dependent context. An extreme effect is demonstrated
by an example in [18].
As a result, it has therefore become routine practice to call the
dominant type (major molecule) of the LH variants present in a
sample [19]. This standard encoding identiﬁes the most abundant
of the length variants, which can clearly be determined in the vast
majority of cases. This can be achieved by determining the highest
signal in a peak pattern that a singular (non-repetitive) nucleotide
(here referred to as ‘‘LHmarker’’) produces as a consequence of the
different length variants present in a sample, e.g. at positions
16196G, 316G or 577G. In many cases this peak pattern displays a
bell-shaped phenotype that shows the dominant LH variant in the
mid-range size.
However, there are examples where this interpretation is not
straight forward as equally quantitative LH variants may be
present that then result in identical signal heights of the LH
marker. In these and other complicated cases we applied the idea
of investigating LH with ﬂuorescence-based amplicon size detec-
tion as demonstrated in principle earlier [3,4,20] by expanding the
assays to cover all ﬁve major LH regions in the mtDNA CR (Fig. 1).
2. Materials and methods
2.1. Generation of synthetic amplicons for mixture analysis
For each LH region two corresponding nucleotide sequences
differing in length by one (polyC-tracts) and two bases (AC-repeat)
were synthesized commercially and PAGE puriﬁed grade (Micro-
synth, Balgach, Switzerland). They were used to evaluate the
detection of mixtures at ratios of 1:1, 1:0.95, 1:0.9, 1:0.85, and
1:0.80 (number of replicates5, Table S1). The shorter variant was
deﬁned as standard (100%, component A) and the longer variant
was added as equal or minor contribution (component B).
2.2. DNA extraction
Blood, buccal swab and autopsy tissue samples were extracted
using the BioRobot M48 workstation (Qiagen, Hilden, Germany),
and the MagAttract DNA M48, Mini Kit (192) according to the
manufacturer’s protocol and the Qiasoft M Operating System
software (ver.2.0E001).
2.3. Quantiﬁcation assay
MtDNA genome equivalents were determined in the extracts
based on 143 bp mtDNA amplicons using a real-time quantitation
PCR (rtqPCR) assay according to [21]. Concentration and purity of
the synthetic DNA fragments were assessed using the NanoDrop
ND-1000 Spectrophotometer (PEQLAB Biotechnologie, Erlangen,
Germany) with standard instrument settings as recommended bythe manufacturer. Extraction blanks as well as negative and
positive controls were carried through the laboratory processes.
2.4. PCR and amplicon sizing analysis
The ﬁve targeted LH regions were ampliﬁed in singleplex PCR
reactions in a total reaction volume of 20 ml including 1 PCR
buffer, 1 mM MgSO4, 200 mM each dNTP, 0.4 U KOD Polymerase
(KOD Hot Start DNA Polymerase, Novagen-Merck KGaA, Darm-
stadt, Germany), 0.25 mg/ml BSA (Serva, Heidelberg, Germany),
0.6% Trehalose, 150 nM each primer (see Table S2). Primers were
designed using Oligo Analyzer from the homepage of Integrated
DNA Technology (http://eu.idtdna.com/home/home.aspx). Unam-
biguous and reproducible results were obtained with 500 mtDNA
Genome Equivalents (mtGE) for the AC repeat region and C-tract
around ntp 460, 100mtGE for the C-tract around ntp 573 and 2000
mtGE for the C-tracts surrounding ntps 16189 and 310. Thermal
cycling was performed on a Gene Amp PCR System 9700 (Applied
Biosystems, AB, Foster City, CA, USA) comprising an initial
denaturation step at 94 8C for 2 min, 30 cycles of 95 8C for 15 s,
56 8C for 7 s. Aliquots of 1.5ml of the ampliﬁcation products were
combinedwith 20 ml deionized formamide and 0.4 ml internal size
standard (Genescan-500 LIZ, AB), heat denatured at 95 8C for
3 min, snap-cooled on ice, and subjected to capillary electropho-
resis on an ABI Prism 3100 Genetic Analyzer using POP 6, 36 cm
capillary arrays and default instrument settings. The data were
analyzed using GeneScan Analysis version 3.7 and Genotyper
version 3.6 (both AB).
3. Results and discussion
The interpretation of LH and the assignment of dominant types
using direct Sanger sequencing are straight forward in the vast
majority of mtDNA haplotypes encountered in population and
forensic genetics. In some instances however, two or even more
length variants may be present in similar quantity, which then
makes the identiﬁcation of a single dominant type difﬁcult or even
impossible. Also, it has been observed that the location of the
sequencing primer has an effect on the depiction of the dominant
type as far as the LH markers are concerned. Therefore multiple
redundant sequencing reactions may not result in the same
dominant typewhen different primers were applied. In these cases
alternative methods may be helpful to solve ambiguities. For this
purpose we designed ﬂuorescent-based amplicon sizing assays
that target the ﬁve most relevant LH regions within the mtDNA CR
(around ntps 16,189, 310, 460, 573, and the AC-repeat between
514 and 524). The PCR setup was performed using the proof
reading KOD Polymerase to avoid non-template 30 overhangs that
would otherwise result in artiﬁcially (by PCR) created length
variation. The primers were selected in a way that each amplicon
can be co-ampliﬁed with any other LH region in duplex format, if
more than one region needs to be investigated in a sample (see
Fig. 2).
3.1. Mixture studies
Since the most difﬁcult constellations for LH interpretation are
(almost) even mixtures of different length variants the perform-
ance of the ﬁve assays was evaluated using synthetically produced
length variants at deﬁned mixture ratios of 1:1, 1:0.95, 1:0.9,
1:0.85, and 1:0.80. The synthesized nucleotide sequences differed
by only one additional C-residue for testing C-tract regions and in
one AC unit for the AC repeat region. For all these mixture samples
the shorter fragment (A) was deﬁned as dominant variant (100%)
and consequently the longer fragment (except for the 1:1 mixture)
always constituted the minor component (B). The latter was
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Fig. 2. Examples of ampliﬁcation plots for the targeted length variant regions with standard samples that do not display heteroplasmy. X-axis sized in bp.
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up to mixture ratios of 1:0.95 for all LH regions (Fig. S1a–g), which
was also conﬁrmed by comparing mean peak height values
between runs. Note that the individual mixtures have been
prepared de novo independently prior to PCR, which may have
caused the relatively high standard deviation values due to
pipetting error. This is also visualized in the graphs that display the
results of the mixture ratio study for all ﬁve LH regions, where the
dotted lines represent the theoretical mixture values and the
straight lines correspond to the regression curves of the measured
mixture ratios. These results demonstrate that the amplicon sizing
assays are suitable for determining the dominant variant in LH
mixtures up to a ratio of 95%.
Additionally, LH mixtures were produced using quantiﬁed DNA
extracts from blood samples of individuals that were known from
prior sequence analysis to vary in length variant regions 310 and
the AC repeat region. Thus, mixture experiments with these
samples as outlined above created a picture that resembles LH. The
amplicon sizing assays were also conductedmultiple times (n  5)
and conﬁrmed the ﬁndings of the analyses performed with the
synthetic DNA fragments (Fig. S1f and g).
3.2. Species speciﬁcity
DNA samples from 14 different vertebrate species were
ampliﬁedwith each amplicon sizing assay (Table S3). The amplicon
sizes obtained for the human sample correspond to the rCRS
variant. The 51 bp fragment observed for the amplicon surround-
ing the C-tract around ntp 573 in the human samplewas also found
in the gorilla, orang-utan and chimpanzeewhere the ampliconwas
slightly larger (52 bp). All other samples brought a 10 bp shorter
amplicon, except for the hare (Lepus europaeus), which gave no
ampliﬁcation product at all. Interestingly, gorilla and orang-utan
samples gave both ampliﬁcation products. For the AC repeat region
only the chimpanzee sample showed an ampliﬁcation product
within the expected amplicon size for humans. Patterns ofmultiple
amplicons with different sizes were found for other animals
including pig, cat, sheep, rat, and falcon. The three other amplicons
did not reveal ampliﬁcation products in the animal samples.
3.3. Population study and GEDNAP trial example
In order to compare results of direct Sanger sequencing and
amplicon sizing we searched the mtDNA datasets of [22–24] for
instances of LH in the electropherograms and typed 48 affected
samples with the amplicon sizing assay. Generally, we found good
agreement between the results in terms of identifying the
dominant type. In some cases the assignment of a dominant type
by Sanger sequencing was not unambiguously possible (Fig. S2a
and b). Therefore it was interesting how the amplicon sizing assays
would perform here. The example presented in Fig. S2a shows LH
in the C-tract around ntp 573 consisting of at least ﬁve detectablelength variants. The sequencing electropherogram suggests the
presence of two almost identical dominant variants with a slight
predominance of the shorter of the two, which is represented by 4
C-insertions (10 C residues in total), as determined by the height of
the LHmarker peak at position 577G (conﬁrmed by the sequencing
electropherogram of the reverse strand). The amplicon sizing assay
revealed at least six LH variants in that sample but conﬁrmed the
relative dominance of the molecule represented by 10 C residues,
even in a clearer way as the results of direct Sanger sequencing
suggest. In another example (Fig. S2b) the HVS-I C-tract around ntp
16189 was difﬁcult to interpret by sequence raw data. The
sequencing electropherograms show three G residues in the LH
marker 16196 with nearly identical peak heights indicating three
almost equally dominant types, two of which (the longer ones)
gave slightly larger peak heights compared to the shorter variant.
The amplicon sizing assay brought a clear dominant type
(16193.1C) and relative ratios of 0.89 and 0.93 for the shorter
and longer variants, respectively.
The third example (GEDNAP trial 38 sample D; concept see
[25]) presents a difﬁcult LH situation in the C-tract around ntp 310.
Two almost equally abundant length variants gave different
dominant types depending on the applied sequencing primers
(Fig. S2c). The majority (22 out of 30) of the GEDNAP participants
reported 309.2C as dominant type, while 7 opted for 309.1C (one
laboratory used a different nomenclature). The amplicon sizing
assay gave a clearer picture with a mixture ratio of about 1:0.75 in
favour of the 309.2C type (Fig. S2c).
3.4. Tissue study
From decomposed autopsy material we received nine different
tissue samples (buccal swab, blood, liver, lung, kidney, spleen,
heart, skin, psoas) from two individuals, where one of them did not
exhibit LH in any of the investigated tissues and regions. The other
individual showed LH in the C-tract around ntp 310 and in the AC
repeat region. As a general observation by Sanger sequencing the
two heteroplasmic regions showed comparable mixtures in each
tissue. However, in the AC repeat region of the blood and the liver
the electropherograms brought a slightly different distribution of
the components (Fig. S3a). In both samples the dominant type was
manifest as (AC)7 while theminor component included 5 AC repeat
units (equivalent to the rCRS). The relative proportion of the minor
component was higher in the liver tissue compared to the blood
sample (by approx. 15%). In the blood and saliva samples the C-
tract around ntp 310 exhibited three dominant variantswith 12, 13
and 14 C residues in the sequence electropherograms, respectively
(Fig. S3b). These ﬁndings were also conﬁrmed with the reverse
sequencing strands. The amplicon sizing approach identiﬁed the
13 C molecule (rCRS) as dominant type in the blood sample with a
ratio of 1:0.84:0.70 compared to the 14 C and 12 Cmolecules. In the
buccal swab this ratio was shifted to 1:1:0.60, resulting in two
indistinguishable dominant types of 12 C and 13 C molecules.
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The interpretation of mtDNA LH has not yet been rigorously
discussed in the forensic community, nor is there general consent
in aharmonizedway of reporting LH.Onemain reasonmay be that
the experimental approach is difﬁcult and sometimes leading to
ambiguous results as also demonstrated in our study. Our data
suggest that ﬂuorescence-based amplicon sizing is more robust
for quantitative determination of dominant LH variants than
direct Sanger sequencing with Big Dye terminators. Also,
amplicon sizing seems to be more sensitive for the determination
of the dominant type, especially in mixtures that appear (almost)
even in sequence electropherograms. In practical work those LH
constellations are most difﬁcult to interprete as a number of
factors seem to inﬂuence the interpretation including the
selection of sequencing primers. The amplicon assay then offers
an independent approach to gain more data that may be useful to
derive an unambiguous decision. In all instances did we observe
that a clear dominant type derived by sequence raw data was
conﬁrmed by amplicon analysis, which conﬁrms the suitability of
themethod. The proposed toolsmay serve as helpful alternative in
cases where a dominant type cannot be retrieved from sequence
raw data.
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